Press release
Migraine Drugs Market: Major Trends Reshaping the Future of the Industry
Migraine Drugs Market
What Will the Migraine Drugs Industry Market Size Be by 2025?
In the past few years, the market size for migraine medication has significantly expanded. It is projected that it will rise from $5.38 billion in 2024 to $5.77 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The progress during the historical period can be credited to advances in drug formulations, heightened awareness and diagnosis, the impact of stress and lifestyle, the proliferation of generic drugs, along with the appearance of cgrp inhibitors.
What's the Long-Term Growth Forecast for the Migraine Drugs Market Size Through 2029?
The market for migraine medications is projected to undergo significant expansion in the forthcoming years, with an estimated value of $7.22 billion in 2029 and a compound annual growth rate (CAGR) of 5.8%. Factors expected to drive growth in the forecast period include the development of personalized medicine, the rise of telemedicine and distant consultations, changes in healthcare policies and insurance coverage, and an increased global incidence of migraines along with combination treatments. Key market trends during this period are anticipated to be specialized therapies, telemedicine and remote consultations, patient-focused strategies, digital therapeutics, the use of biosimilars in migraine treatment, and ongoing clinical research and trials.
View the full report here:
https://www.thebusinessresearchcompany.com/report/migraine-drugs-global-market-report
What Are the Key Growth Drivers Fueling the Migraine Drugs Market Expansion?
The expanding number of females worldwide is predicted to fuel the growth of the migraine drugs market. The term "female population" refers to the count of females of all ages residing in a particular region or country during a given timeframe. The frequency of migraines is considerably greater among females as compared to males, largely attributed to genetics, hormones, and environmental factors. For example, the World Population Prospects 2022, as presented by the United Nations, an intergovernmental institution based in the US, projected that the global female population would reach 4.00 billion in 2022, comprising 49.75% of the total global population, with a projection of outnumbering men by 2049. Therefore, the expanding female demographic contributes significantly to the growth of the market for migraine medications. Migraine Drugs Market Driver: Heightened Prevalence of Migraines Fuels Growth in the Migraine Drug Market
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13484&type=smp
What Are the Key Trends Driving Migraine Drugs Market Growth?
Key players in the migraine pharmaceutical market, such as Zavzpret, are striving to gain a competitive advantage by developing inventive products to better cater to patient needs. Zavzpret is a medical nasal spray specially formulated to treat acute migraines in adults with or without aura. Specifically, in March 2023, Pfizer, a pharmaceutical enterprise based in the US, obtained the green light from the Food and Drug Administration, another US federal entity, for Zavzpret. This nasal spray is unique as the first and only zavegepant, a CGRP receptor antagonist, approved for acute treatment of migraines. The drug focuses on the calcitonin gene-related peptide or CGRP and is meant to acutely treat migraines. This fresh introduction of Zavzpret opens a new avenue of treatment for migraine sufferers especially for those who experience nausea, vomiting during migraine strikes or those who are unable to use triptans due to cardiovascular threats.
How Is the Migraine Drugs Market Segmented?
The migraine drugs market covered in this report is segmented -
1) By Drug Class: Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants
2) By Route of Administration: Oral, Injectable, Other Routes
3) By End-User: Hospitals And Clinics, Retail Pharmacy, Online Pharmacy, Other End Users
Subsegments:
1) By Triptans: Sumatriptan, Rizatriptan, Zolmitriptan, Eletriptan
2) By Beta Blockers: Propranolol, Metoprolol, Timolol
3) By Angiotensin Blockers: Candesartan, Losartan
4) By Tricyclics: Amitriptyline, Nortriptyline
5) By Anticonvulsants: Topiramate, Valproate
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13484&type=smp
Which Companies Are Leading the Charge in Migraine Drugs Market Innovation?
Major companies operating in the migraine drugs market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., AbbVie Inc., Sanofi SA, Novartis AG, AstraZeneca, Abbott Laboratories, GlaxoSmithKline plc., Eli Lilly and Company, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Dr Reddy's Laboratories Ltd., H. Lundbeck A/S, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Neurelis Inc., ALDER BIOPHARMACEUTICALS INC., eNeura Inc., Winston Pharmaceuticals Ltd.
Which Regions Are Leading the Global Migraine Drugs Market in Revenue?
North America was the largest region in the migraine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the migraine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13484
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market: Major Trends Reshaping the Future of the Industry here
News-ID: 4126333 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
